Search by Drug Name or NDC
NDC 00093-5031-56 Tiagabine Hydrochloride 4 mg/1 Details
Tiagabine Hydrochloride 4 mg/1
Tiagabine Hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is TIAGABINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Tiagabine is used in combination with other medications to treat partial seizures (a type of epilepsy). Tiagabine is in a class of medications called anticonvulsants. It is not known exactly how tiagabine works, but it increases the amount of natural chemicals in the brain that prevent seizure activity.
Related Packages: 00093-5031-56Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tiagabine
Product Information
| NDC | 00093-5031 |
|---|---|
| Product ID | 0093-5031_774a4b2f-e96b-4d6a-a9ff-122279d46b6f |
| Associated GPIs | 72170070100305 |
| GCN Sequence Number | 034737 |
| GCN Sequence Number Description | tiagabine HCl TABLET 4 MG ORAL |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 37980 |
| HICL Sequence Number | 015773 |
| HICL Sequence Number Description | TIAGABINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Tiagabine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tiagabine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | mg/1 |
| Substance Name | TIAGABINE HYDROCHLORIDE |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Pharmaceutical Class | Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA020646 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00093-5031-56 (00093503156)
| NDC Package Code | 0093-5031-56 |
|---|---|
| Billing NDC | 00093503156 |
| Package | 30 TABLET, FILM COATED in 1 BOTTLE (0093-5031-56) |
| Marketing Start Date | 2016-07-18 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.91227 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | TIAGABINE HCL 4 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 6 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis